Metropolis Healthcare Limited

Equities

METROPOLIS

INE112L01020

Healthcare Facilities & Services

End-of-day quote NSE India S.E. Other stock markets 03:30:00 15/05/2024 am IST			5-day change	1st Jan Change
1,850 ^INR	+0.77%		+4.03%	+10.26%

10/05	India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	RE
11/04	Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue	MT

Metropolis Healthcare Limited Announces Consolidated Revenue Results for the Fourth Quarter Ended March 31, 2024

April 10, 2024 at 08:44 pm IST

Metropolis Healthcare Limited announced Consolidated revenue results for the fourth quarter ended March 31, 2024. For the period, Core business revenue grew approximately 15% year on year. B2C revenues grew at approximately 18% year on year.

Latest news about Metropolis Healthcare Limited

India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	10/05	RE
Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue	11/04	MT
Metropolis Healthcare Limited Announces Consolidated Revenue Results for the Fourth Quarter Ended March 31, 2024	10/04	CI
Metropolis Healthcare's Consolidated Net Profit Declines in Fiscal Q3	05/02	MT
Transcript : Metropolis Healthcare Limited, Q3 2024 Earnings Call, Feb 05, 2024	05/02
Metropolis Healthcare Limited Announces Management Changes	02/02	CI
Metropolis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02/02	CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	01/02	RE
Transcript : Metropolis Healthcare Limited, Q2 2024 Earnings Call, Nov 06, 2023	06/11
Metropolis Healthcare Limited Approves and Declares Payment of an Interim Dividend for the Financial Year 2023-24	04/11	CI
Crisil Keeps AA- Rating on Metropolis Healthcare's Bank Loans; Revises Outlook to Stable	05/23/05	MT
Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023	06/23/06	CI
Metropolis Healthcare Limited Appoints Mohan Menon as Chief Marketing Officer	07/23/07	CI
Metropolis Healthcare's Consolidated Profit Drops in Fiscal Q1	04/23/04	MT
Metropolis Healthcare to Seek Smaller Bolt-On Acquisitions	03/23/03	CI
Transcript : Metropolis Healthcare Limited, Q1 2024 Earnings Call, Aug 03, 2023	03/23/03
Metropolis Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	02/23/02	CI
Metropolis Healthcare Limited Appoints Neha Shah as Interim Company Secretary	20/23/20	CI
Metropolis Healthcare Seeks Acquisitions	17/23/17	CI
Transcript : Metropolis Healthcare Limited, Q4 2023 Earnings Call, May 17, 2023	17/23/17
Metropolis Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	16/23/16	CI
India's Dr. Lal PathLabs reports decline in Q4 profit	11/23/11	RE
Metropolis Healthcare Limited Approves Reconstitution of Board Committees	01/23/01	CI
Metropolis Healthcare's Consolidated Profit Slides in Fiscal Q3; EPS, Revenue Miss Estimate	13/23/13	MT
Transcript : Metropolis Healthcare Limited, Q3 2023 Earnings Call, Feb 13, 2023	13/23/13

Chart Metropolis Healthcare Limited

Duration

Period

More charts

Company Profile

Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.

Sector

Healthcare Facilities & Services

Calendar

07/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Metropolis Healthcare Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1,850 INR

Average target price

1,733 INR

Spread / Average Target

-6.35%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
METROPOLIS HEALTHCARE LIMITED	+10.26%	1.13B
SONIC HEALTHCARE LIMITED	-16.80%	8.79B
RADNET, INC.	+64.22%	4.19B
DR. LAL PATHLABS LIMITED	-4.03%	2.48B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-42.54%	2.29B
NEOGENOMICS, INC.	-6.30%	1.97B
FLEURY S.A.	-19.96%	1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-41.24%	1.22B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+18.74%	933M
OPKO HEALTH, INC.	-10.26%	910M

Medical & Diagnostic Laboratories